SCHEMBL2809045

SCHEMBL2809045

CCOC(=O)c1[nH]c2ccccc2c1-c1cc2ccccc2o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.54
TP53 P04637 1/20 0.54
CASP3 P42574 1/20 0.54
SENP8 Q96LD8 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
SENP6 Q9GZR1 1/20 0.54
KDM4E B2RXH2 8/20 0.50
ALDH1A1 P00352 5/20 0.50
HTR6 P50406 2/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50
HPGD P15428 3/20 0.49
TUBB4A P04350 2/20 0.49
TUBB P07437 2/20 0.49
TUBA3C P0DPH7 2/20 0.49
TUBA1B P68363 2/20 0.49
TUBA4A P68366 2/20 0.49
TUBB4B P68371 2/20 0.49
TUBB3 Q13509 2/20 0.49
TUBB2A Q13885 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22443293 0.79 KDM4E (0.54) MAPTKDM4EALDH1A1HTR6HPGD
SCHEMBL2956667 0.76 ALDH1A1 (0.73) MAPTKDM4EALDH1A1HTR6HPGD
SCHEMBL24487443 0.74 HTR6 (0.61) MAPTTP53KDM4EALDH1A1HTR6
SCHEMBL2205697 0.74 KDM4E (0.57) MAPTKDM4EALDH1A1HTR6HPGD
SCHEMBL7679887 0.74 MAPT (0.60) MAPTKDM4EALDH1A1HTR6HPGD
SCHEMBL2880010 0.73 KDM4E (0.66) MAPTKDM4EALDH1A1HTR6HPGD
SCHEMBL39913 0.73 ALDH1A1 (0.55) MAPTKDM4EALDH1A1HTR6HPGD
SCHEMBL18496766 0.73 MAPT (0.59) MAPTTP53CASP3SENP8SENP7
SCHEMBL27976169 0.73 TUBB4A (0.53) MAPTKDM4EALDH1A1HPGDTUBB4A
SCHEMBL24487442 0.72 KDM4E (0.55) MAPTKDM4EALDH1A1HTR6HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
EP-2081894-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SmithKline Beecham Corporation (US) 2009-07-29 EP disclosed
WO-2008028118-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SMITHKLINE BEECHAM CORPORAITON (US) 2008-03-06 WO disclosed
WO-2008028118-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SMITHKLINE BEECHAM CORPORAITON (US) 2008-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators PPARD, PPARA, PPARG MAPT 2916/4885TP53 1320/4885CASP3 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.